There's a lot to like about the life sciences and diagnostics company, even after the COVID-19 pandemic.
News & Analysis: Danaher
The life sciences and diagnostics company is a big winner of the COVID-19 pandemic.
The life sciences and diagnostic company is set up for another great year.
DHR earnings call for the period ending March 31, 2021.
The key to the stock's prospects will be to continue its earnings trajectory in a post-COVID-19 world.
DHR earnings call for the period ending December 31, 2020.
The bioprocessing technology company gained momentum during the coronavirus pandemic.
Analyzing the investment case for one of the big winners from the coronavirus pandemic.
The company's diagnostic tests and life sciences research tools are being extensively used in the fight against the pandemic.
DHR earnings call for the period ending October 2, 2020.